Holen Sie sich die Stockscreener-App
0.9301
2.09%
-0.0199
Handel nachbörslich:
.92
-0.0101
-1.09%
Schlusskurs vom Vortag:
$0.95
Offen:
$0.959
24-Stunden-Volumen:
25,821
Relative Volume:
0.11
Marktkapitalisierung:
$4.73M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-0.1942
EPS:
-4.79
Netto-Cashflow:
$-16.95M
1W Leistung:
-3.11%
1M Leistung:
-3.53%
6M Leistung:
+52.48%
1J Leistung:
+449.06%
1-Tages-Spanne:
$0.92
$0.965
1-Wochen-Bereich:
$0.92
$1.0034
52-Wochen-Spanne:
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Vergleichen Sie MTNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
0.9301 | 4.83M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
What are Matinas BioPharma Holdings Inc. company’s key revenue driversGet daily expert analysis on top stocks - jammulinksnews.com
How does Matinas BioPharma Holdings Inc. compare to its industry peersGet exclusive market analysis for investors - jammulinksnews.com
How does Matinas BioPharma Holdings Inc. generate profit in a changing economyAchieve triple-digit returns with smart investing - jammulinksnews.com
What makes Matinas BioPharma Holdings Inc. stock price move sharplyFree Stock Selection - jammulinksnews.com
Competitive Positioning of Matinas BioPharma Holdings Inc.: Is It Leading or LaggingDaily Swing Candidates - Newser
Matinas BioPharma Holdings Inc. Stock Support and Resistance Levels You Should KnowFree Day Trading Recommendations - Newser
Should I hold or sell Matinas BioPharma Holdings Inc. stock in 2025Sky-high profits - jammulinksnews.com
Matinas BioPharma Holdings Inc. Stock Performance After Earnings: Historical InsightsFree Stock Market Group - Newser
What are the latest earnings results for Matinas BioPharma Holdings Inc.High-return market picks - jammulinksnews.com
Is Matinas BioPharma Holdings Inc. a good long term investmentLightning-fast growth - PrintWeekIndia
What drives Matinas BioPharma Holdings Inc. stock priceMarket-beating returns - PrintWeekIndia
What analysts say about Matinas BioPharma Holdings Inc. stockExceptional market positioning - Autocar Professional
Matinas BioPharma Holdings Inc. Stock Analysis and ForecastOutstanding capital growth - PrintWeekIndia
What analysts say about HASI stockFree Investment Timing Strategies - jammulinksnews.com
How Matinas BioPharma Holdings Inc. stock performs during market volatilitySmart Return Focused Trading - Newser
Is Renovaro Inc. a good long term investmentSuperior capital gains - jammulinksnews.com
What analysts say about WRAP stockOutstanding capital returns - jammulinksnews.com
Why Matinas BioPharma Holdings Inc. stock attracts strong analyst attentionQuick Profit Idea Stream - Newser
Why Hayward Holdings Inc. stock attracts strong analyst attentionFree Stock Movement Tracking - Newser
Aspergillosis Pipeline 2025: FDA Updates, Therapy - openPR.com
Diversification Wins: Global ETFs Shine in First Half of 2025 - The Globe and Mail
Matinas BioPharma Approves 2025 Equity Incentive Plan - TipRanks
MTNB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Pre-market Movers: HCTI, KLTO, INTS, HSDT... - RTTNews
Kalkine Matinas BioPharma Surges Amid NYSE Composite Market Momentum - Kalkine Media
Matinas Biopharma (NYSE:MTNB) Trading 5.7% Higher – Here’s Why - Defense World
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):